United States Cancer Treatment Drugs Market Research Report Forecast 2017-2021 Chapter 1 Cancer Treatment Drugs Market Overview 1.1 Product Overview and Scope of Cancer Treatment Drugs 1.2 Cancer Treatment Drugs Market Segmentation by Type 1.2.1 United States Production Market Share of Cancer Treatment Drugs by Type in 2015 1.2.1 Type I 1.2.2 Type II 1.2.3 Type III 1.3 Cancer Treatment Drugs Market Segmentation by Application 1.3.1 Cancer Treatment Drugs Consumption Market Share by Application in 2015 1.3.2 Application I 1.3.3 Application II 1.3.4 Application III 1.4 United States Market Size Sales (Value) and Revenue (Volume) of Cancer Treatment Drugs (2011-2021) Chapter 2 United States Economic Impact on Cancer Treatment Drugs Industry 2.1 United States Macroeconomic Analysis 2.2 United States Macroeconomic Environment Development Trend Chapter 3 United States Cancer Treatment Drugs Market Competition by Manufacturers 3.1 United States Cancer Treatment Drugs Production and Share by Manufacturers (2015 and 2016) 3.2 United States Cancer Treatment Drugs Revenue and Share by Manufacturers (2015 and 2016) 3.3 United States Cancer Treatment Drugs Average Price by Manufacturers (2015 and 2016) 3.4 Manufacturers Cancer Treatment Drugs Manufacturing Base Distribution, Production Area and Product Type 3.5 Cancer Treatment Drugs Market Competitive Situation and Trends 3.5.1 Cancer Treatment Drugs Market Concentration Rate 3.5.2 Cancer Treatment Drugs Market Share of Top 3 and Top 5 Manufacturers 3.5.3 Mergers & Acquisitions, Expansion Chapter 4 United States Cancer Treatment Drugs Production, Revenue (Value), Price Trend by Type 4.1 United States Cancer Treatment Drugs Production and Market Share by Type (2012-2017) 4.2 United States Cancer Treatment Drugs Revenue and Market Share by Type (2012-2017) 4.3 United States Cancer Treatment Drugs Price by Type (2012-2017) 4.4 United States Cancer Treatment Drugs Production Growth by Type (2012-2017) Chapter 5 United States Cancer Treatment Drugs Market Analysis by Application 5.1 United States Cancer Treatment Drugs Consumption and Market Share by Application (2012-2017) 5.2 United States Cancer Treatment Drugs Consumption Growth Rate by Application (2012-2017) 5.3 Market Drivers and Opportunities 5.3.1 Potential Applications 5.3.2 Emerging Markets/Countries Chapter 6 United States Cancer Treatment Drugs Manufacturers Analysis 6.1 Roche 6.1.1 Company Basic Information, Manufacturing Base and Competitors 6.1.2 Product Type, Application and Specification 6.1.3 Production, Revenue, Price and Gross Margin (2012-2017) 6.1.4 Business Overview 6.2 Novartis 6.2.1 Company Basic Information, Manufacturing Base and Competitors 6.2.2 Product Type, Application and Specification 6.2.3 Production, Revenue, Price and Gross Margin (2012-2017) 6.2.4 Business Overview 6.3 Celgene 6.3.1 Company Basic Information, Manufacturing Base and Competitors 6.3.2 Product Type, Application and Specification 6.3.3 Production, Revenue, Price and Gross Margin (2012-2017) 6.3.4 Business Overview 6.4 Amgen 6.4.1 Company Basic Information, Manufacturing Base and Competitors 6.4.2 Product Type, Application and Specification 6.4.3 Production, Revenue, Price and Gross Margin (2012-2017) 6.4.4 Business Overview 6.5 Johnson & Johnson 6.5.1 Company Basic Information, Manufacturing Base and Competitors 6.5.2 Product Type, Application and Specification 6.5.3 Production, Revenue, Price and Gross Margin (2012-2017) 6.5.4 Business Overview 6.6 Bristol-Myers Squibb 6.6.1 Company Basic Information, Manufacturing Base and Competitors 6.6.2 Product Type, Application and Specification 6.6.3 Production, Revenue, Price and Gross Margin (2012-2017) 6.6.4 Business Overview 6.7 Takeda 6.7.1 Company Basic Information, Manufacturing Base and Competitors 6.7.2 Product Type, Application and Specification 6.7.3 Production, Revenue, Price and Gross Margin (2012-2017) 6.7.4 Business Overview 6.8 Eli Lilly 6.6.1 Company Basic Information, Manufacturing Base and Competitors 6.6.2 Product Type, Application and Specification 6.6.3 Production, Revenue, Price and Gross Margin (2012-2017) 6.6.4 Business Overview 6.9 Pfizer 6.9.1 Company Basic Information, Manufacturing Base and Competitors 6.9.2 Product Type, Application and Specification 6.9.3 Production, Revenue, Price and Gross Margin (2012-2017) 6.9.4 Business Overview … Chapter 7 Cancer Treatment Drugs Manufacturing Cost Analysis 7.1 Cancer Treatment Drugs Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Price Trend of Key Raw Materials 7.1.3 Key Suppliers of Raw Materials 7.1.4 Market Concentration Rate of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.2.1 Raw Materials 7.2.2 Labor Cost 7.2.3 Manufacturing Expenses 7.3 Manufacturing Process Analysis of Cancer Treatment Drugs Chapter 8 Industrial Chain, Sourcing Strategy and Downstream Buyers 8.1 Cancer Treatment Drugs Industrial Chain Analysis 8.2 Upstream Raw Materials Sourcing 8.3 Raw Materials Sources of Cancer Treatment Drugs Major Manufacturers in 2015 8.4 Downstream Buyers Chapter 9 Marketing Strategy Analysis, Distributors/Traders 9.1 Marketing Channel 9.1.1 Direct Marketing 9.1.2 Indirect Marketing 9.1.3 Marketing Channel Development Trend 9.2 Market Positioning 9.2.1 Pricing Strategy 9.2.2 Brand Strategy 9.2.3 Target Client 9.3 Distributors/Traders List Chapter 10 Market Effect Factors Analysis 10.1 Technology Progress/Risk 10.1.1 Substitutes Threat 10.1.2 Technology Progress in Related Industry 10.2 Consumer Needs/Customer Preference Change 10.3 Economic/Political Environmental Change Chapter 11 United States Cancer Treatment Drugs Market Forecast (2017-2021) 11.1 United States Cancer Treatment Drugs Production, Revenue Forecast (2017-2021) 11.2 United States Cancer Treatment Drugs Production, Consumption Forecast by Regions (2017-2021) 11.3 United States Cancer Treatment Drugs Production Forecast by Type (2017-2021) 11.4 United States Cancer Treatment Drugs Consumption Forecast by Application (2017-2021) 11.5 Cancer Treatment Drugs Price Forecast (2017-2021) Chapter 12 Appendix

Figure Picture of Cancer Treatment Drugs Table Classification of Cancer Treatment Drugs Figure United States Sales Market Share of Cancer Treatment Drugs by Type in 2015 Table Application of Cancer Treatment Drugs Figure United States Sales Market Share of Cancer Treatment Drugs by Application in 2015 Figure United States Cancer Treatment Drugs Sales and Growth Rate (2011-2021) Figure United States Cancer Treatment Drugs Revenue and Growth Rate (2011-2021) Table United States Cancer Treatment Drugs Sales of Key Manufacturers (2015 and 2016) Table United States Cancer Treatment Drugs Sales Share by Manufacturers (2015 and 2016) Figure 2015 Cancer Treatment Drugs Sales Share by Manufacturers Figure 2016 Cancer Treatment Drugs Sales Share by Manufacturers Table United States Cancer Treatment Drugs Revenue by Manufacturers (2015 and 2016) Table United States Cancer Treatment Drugs Revenue Share by Manufacturers (2015 and 2016) Table 2015 United States Cancer Treatment Drugs Revenue Share by Manufacturers Table 2016 United States Cancer Treatment Drugs Revenue Share by Manufacturers Table United States Market Cancer Treatment Drugs Average Price of Key Manufacturers (2015 and 2016) Figure United States Market Cancer Treatment Drugs Average Price of Key Manufacturers in 2015 Figure Cancer Treatment Drugs Market Share of Top 3 Manufacturers Figure Cancer Treatment Drugs Market Share of Top 5 Manufacturers Table United States Cancer Treatment Drugs Sales by Type (2012-2017) Table United States Cancer Treatment Drugs Sales Share by Type (2012-2017) Figure United States Cancer Treatment Drugs Sales Market Share by Type in 2015 Table United States Cancer Treatment Drugs Revenue and Market Share by Type (2012-2017) Table United States Cancer Treatment Drugs Revenue Share by Type (2012-2017) Figure Revenue Market Share of Cancer Treatment Drugs by Type (2012-2017) Table United States Cancer Treatment Drugs Price by Type (2012-2017) Figure United States Cancer Treatment Drugs Sales Growth Rate by Type (2012-2017) Table United States Cancer Treatment Drugs Sales by Application (2012-2017) Table United States Cancer Treatment Drugs Sales Market Share by Application (2012-2017) Figure United States Cancer Treatment Drugs Sales Market Share by Application in 2015 Table United States Cancer Treatment Drugs Sales Growth Rate by Application (2012-2017) Figure United States Cancer Treatment Drugs Sales Growth Rate by Application (2012-2017) Table Roche Basic Information, Manufacturing Base, Production Area and Its Competitors Table Roche Cancer Treatment Drugs Production, Revenue, Price and Gross Margin (2012-2017) Table Roche Cancer Treatment Drugs Market Share (2012-2017) Table Novartis Basic Information, Manufacturing Base, Production Area and Its Competitors Table Novartis Cancer Treatment Drugs Production, Revenue, Price and Gross Margin (2012-2017) Table Novartis Cancer Treatment Drugs Market Share (2012-2017) Table Celgene Basic Information, Manufacturing Base, Production Area and Its Competitors Table Celgene Cancer Treatment Drugs Production, Revenue, Price and Gross Margin (2012-2017) Table Celgene Cancer Treatment Drugs Market Share (2012-2017) Table Amgen Basic Information, Manufacturing Base, Production Area and Its Competitors Table Amgen Cancer Treatment Drugs Production, Revenue, Price and Gross Margin (2012-2017) Table Amgen Cancer Treatment Drugs Market Share (2012-2017) Table Johnson & Johnson Basic Information, Manufacturing Base, Production Area and Its Competitors Table Johnson & Johnson Cancer Treatment Drugs Production, Revenue, Price and Gross Margin (2012-2017) Table Johnson & Johnson Cancer Treatment Drugs Market Share (2012-2017) Table Bristol-Myers Squibb Basic Information, Manufacturing Base, Production Area and Its Competitors Table Bristol-Myers Squibb Cancer Treatment Drugs Production, Revenue, Price and Gross Margin (2012-2017) Table Bristol-Myers Squibb Cancer Treatment Drugs Market Share (2012-2017) Table Takeda Basic Information, Manufacturing Base, Production Area and Its Competitors Table Takeda Cancer Treatment Drugs Production, Revenue, Price and Gross Margin (2012-2017) Table Takeda Cancer Treatment Drugs Market Share (2012-2017) Table Eli Lilly Basic Information, Manufacturing Base, Production Area and Its Competitors Table Eli Lilly Cancer Treatment Drugs Production, Revenue, Price and Gross Margin (2012-2017) Table Eli Lilly Cancer Treatment Drugs Market Share (2012-2017) Table Pfizer Basic Information, Manufacturing Base, Production Area and Its Competitors Table Pfizer Cancer Treatment Drugs Production, Revenue, Price and Gross Margin (2012-2017) Table Pfizer Cancer Treatment Drugs Market Share (2012-2017) Table Production Base and Market Concentration Rate of Raw Material Figure Price Trend of Key Raw Materials Table Key Suppliers of Raw Materials Figure Manufacturing Cost Structure of Cancer Treatment Drugs Figure Manufacturing Process Analysis of Cancer Treatment Drugs Figure Cancer Treatment Drugs Industrial Chain Analysis Table Raw Materials Sources of Cancer Treatment Drugs Major Manufacturers in 2015 Table Major Buyers of Cancer Treatment Drugs Table Distributors/Traders List Figure United States Cancer Treatment Drugs Production and Growth Rate Forecast (2017-2021) Figure United States Cancer Treatment Drugs Revenue and Growth Rate Forecast (2017-2021) Table United States Cancer Treatment Drugs Production Forecast by Type (2017-2021)

Roche Novartis Celgene Amgen Johnson & Johnson Bristol-Myers Squibb Takeda Eli Lilly Pfizer AstraZeneca Astellas Sanofi Bayer Merck & Co. Biogen Idec Kyowa Hakko Kirin Otsuka Teva Eisai Merck KGaA Ipsen AbbVie Gilead Sciences